These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6323206)

  • 1. Intraocular pressure, ocular toxicity and neurotoxicity after administration of delta 9-tetrahydrocannabinol or cannabichromene.
    Colasanti BK; Powell SR; Craig CR
    Exp Eye Res; 1984 Jan; 38(1):63-71. PubMed ID: 6323206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol.
    Colasanti BK; Craig CR; Allara RD
    Exp Eye Res; 1984 Sep; 39(3):251-9. PubMed ID: 6499952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol.
    Colasanti BK; Brown RE; Craig CR
    Gen Pharmacol; 1984; 15(6):479-84. PubMed ID: 6098513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the ocular and central effects of delta 9-tetrahydrocannabinol and cannabigerol.
    Colasanti BK
    J Ocul Pharmacol; 1990; 6(4):259-69. PubMed ID: 1965836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraocular pressure, ocular toxicity and neurotoxicity in response to 11-hydroxy-delta 9-tetrahydrocannabinol and 1-nantradol.
    Colasanti BK
    J Ocul Pharmacol; 1985; 1(2):123-35. PubMed ID: 2851633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of delta 9-tetrahydrocannabinol on intraocular pressure after removal of autonomic input.
    Colasanti BK; Powell SR
    J Ocul Pharmacol; 1985; 1(1):47-57. PubMed ID: 2851632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system and peripheral mechanisms in ocular hypotensive effect of cannabinoids.
    Liu JH; Dacus AC
    Arch Ophthalmol; 1987 Feb; 105(2):245-8. PubMed ID: 3813958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular effects of topical administration of delta 9-tetrahydrocannabinol in man.
    Green K; Roth M
    Arch Ophthalmol; 1982 Feb; 100(2):265-7. PubMed ID: 6279061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraocular pressure following systemic administration of cannabinoids.
    Green K; Symonds CM; Oliver NW; Elijah RD
    Curr Eye Res; 1982-1983; 2(4):247-53. PubMed ID: 6295702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of delta 9-tetrahydrocannabinol on intraocular pressure in the anaesthetized cat.
    Innemee HC; Hermans AJ; van Zwieten PA
    Doc Ophthalmol; 1980 Apr; 48(2):235-41. PubMed ID: 6249559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats.
    Colasanti BK; Lindamood C; Craig CR
    Pharmacol Biochem Behav; 1982 Apr; 16(4):573-8. PubMed ID: 6280204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perinatal exposure to cannabichromene and delta 9-tetrahydrocannabinol: separate and combined effects on viability of pups and on male reproductive system at maturity.
    Hatoum NS; Davis WM; Elsohly MA; Turner CE
    Toxicol Lett; 1981 May; 8(3):141-6. PubMed ID: 6264652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between delta-9-tetrahydrocannabinol and indomethacin.
    Green K; Kearse EC; McIntyre OL
    Ophthalmic Res; 2001; 33(4):217-20. PubMed ID: 11464074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.
    Adelli GR; Bhagav P; Taskar P; Hingorani T; Pettaway S; Gul W; ElSohly MA; Repka MA; Majumdar S
    Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2167-2179. PubMed ID: 28399267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study.
    Tomida I; Azuara-Blanco A; House H; Flint M; Pertwee RG; Robson PJ
    J Glaucoma; 2006 Oct; 15(5):349-53. PubMed ID: 16988594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute delta 9-THC administration on EEG and EEG power spectra in the rat.
    Buonamici M; Young GA; Khazan N
    Neuropharmacology; 1982 Aug; 21(8):825-9. PubMed ID: 6289162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
    Oviedo A; Glowa J; Herkenham M
    Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
    Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
    Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of the intraocular pressure (IOP) lowering effect of systemic dexanabinol (HU-211), a non-psychotropic cannabinoid.
    Beilin M; Neumann R; Belkin M; Green K; Bar-Ilan A
    J Ocul Pharmacol Ther; 2000 Jun; 16(3):217-30. PubMed ID: 10872919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids in glaucoma II: the effect of different cannabinoids on intraocular pressure of the rabbit.
    ElSohly MA; Harland EC; Benigni DA; Waller CW
    Curr Eye Res; 1984 Jun; 3(6):841-50. PubMed ID: 6329602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.